Athens General Hospital 'Evangelismos' is one of the largest public hospitals in Greece. It is located in a sub-neighbourhood of Kolonaki named after it, Evangelismos.

During the past decade, General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma" are "Multiple Myeloma" (2 trials) and "Relapse Multiple Myeloma" (1 trials). Many other conditions were trialed in "General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma" in a lesser frequency.

Most popular intervention types in "General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Bortezomib" (1 trials), "Daratumumab" (1 trials), "Melphalan Flufenamide" (1 trials) and "Selinexor" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma" are 2 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".